The goal of this study was to determine if depletion of glutathione (GSH) and inhibition of thioredoxin (Trx) reductase (TrxR) activity could enhance radiation responses in human breast cancer stem cells by a mechanism involving thiol-dependent oxidative stress. The following were used to inhibit GSH and Trx metabolism: buthionine sulfoximine (BSO), a GSH synthesis inhibitor; sulfasalazine (SSZ), an inhibitor of x c -cysteine/glutamate antiporter; auranofin (Au), a thioredoxin reductase inhibitor; or 2-AAPA, a GSHreductase inhibitor. Clonogenic survival, Matrigel assays, flow cytometry cancer stem cell assays (CD44 + CD24 -ESA + or ALDH1) and human tumor xenograft models were used to determine the antitumor activity of drug and radiation combinations. Combined inhibition of GSH and Trx metabolism enhanced cancer cell clonogenic killing and radiation responses in human breast and pancreatic cancer cells via a mechanism that could be inhibited by N-acetylcysteine (NAC). Au, BSO and radiation also significantly decreased breast cancer cell migration and invasion in a thiol-dependent manner that could be inhibited by NAC. In addition, pretreating cells with Au sensitized breast cancer stem cell populations to radiation in vitro as determined by CD44 + CD24 -ESA + or ALDH1. Combined administration of Au and BSO, given prior to irradiation, significantly increased the survival of mice with human breast cancer xenografts, and decreased the number of ALDH1 + cancer stem cells. These results indicate that combined inhibition of GSH-and Trx-dependent thiol metabolism using pharmacologically relevant agents can enhance responses of human breast cancer stem cells to radiation both in vitro and in vivo. Ó 2016 by Radiation Research Society
INTRODUCTION
Recurrence rates for breast cancer within 10 years of surgery followed by radiation therapy range from 8-13%. Unfortunately, many of these patients will have metastases or locally extensive disease at the time of recurrence (1) . Pancreatic cancer has a five-year survival rate even after surgical resection of less than 20%. Investigational therapies that use radiation in combination with resection are being pursued in an attempt to decrease metastasis (2) . It has been hypothesized that a small subset of intrinsically radioresistant early progenitor cancer stem cells are responsible for tumor regrowth and metastasis (3, 4) . Novel therapeutic approaches in breast and pancreatic cancer that would enhance radiation response of the bulk of the tumor and target the migration and invasion of cancer stem cells would be of significant clinical benefit.
Glutathione-(GSH) and thioredoxin-(Trx) dependent metabolism are the main cellular thiol-dependent pathways that scavenge hydroperoxides, allowing for the maintenance of cell redox potential while preventing and repairing oxidative damage. GSH is a tripeptide and the thiol group on the cysteine molecule is able to donate reducing equivalents to unstable molecules in the cell. Trx is a protein that, like GSH, donates reducing equivalents to a multitude of metabolic reactions using an intermolecular cysteine thiol-disulfide exchange. Previously published studies have demonstrated increased levels of GSH and Trx in breast and pancreatic tumors compared to corresponding normal tissues (5, 6) . In addition, elevated thiol metabolism has also been associated with increases in tumor grade and poorer patient outcomes (6) . It has been hypothesized that cancer cells increase GSH-and Trxdependent metabolism to protect against hydroperoxides produced by metabolism, and that this increase in antioxidant capacity leads to resistance to radiation and chemotherapy (7, 8) . Redox status also mediates embryonic stem cell differentiation with substantial accumulation of oxidized glutathione (GSSG) by day 4 of differentiation (9) . Interestingly, previously reported studies have also shown that cancer stem cell self-renewal as well as radiation sensitivity may potentially be affected by reactive oxygen species (ROS) and thiol antioxidant capacity (3, 4, 10) .
In our previously reported work, we demonstrated that combined inhibition of both GSH-and Trx-dependent metabolism was necessary to consistently achieve maximal chemosensitization of human lung and breast cancer cells via thiol-mediated oxidative stress (7, 8) . In the current study we extend this research to examine radiation responses after manipulation with other therapeutically relevant thiol modifying agents [i.e., sulfasalazine and 2-acetylamino-3-(4-[2-acetylamino-2-carboxyethylsulfanylthiocarbonyamino]phenylthiocarbamoylsulfanyl) propionic acid (2-AAPA)], as well as combined manipulations of glutathione and thioredoxin metabolism in early progenitor breast cancer stem cells.
To manipulate GSH levels, an inhibitor of the ratelimiting step in GSH synthesis, buthionine sulfoximine (BSO), was utilized because it is well tolerated in humans at blood levels up to 1 mM (11). In addition, GSH levels were manipulated by limiting the availability of cysteine using sulfasalazine (SSZ), which inhibits the x c -cystine/glutamate antiporter and is well tolerated in humans at blood levels of 100 lM after oral administration (12) . Furthermore, SSZ has been shown to decrease GSH and sensitize pancreatic tumors to gemcitabine (13) . A novel inhibitor of glutathione reductase (GR), 2-AAPA has been used to restrict GSH metabolism by inhibiting the recycling of GSSG to GSH by glutathione reductase (14) . Thioredoxin metabolism was manipulated using an excellent inhibitor of both cytosolic and mitochondrial thioredoxin reductase (TrxR), auranofin (Au), which is a gold phosphine used safely in humans at plasma levels of 1-2 lM (15, 16).
In the current study, GSH-and Trx-dependent metabolism was manipulated using BSO, SSZ, 2-AAPA and Au, in combination with radiation, to determine effects on clonogenic survival, DNA damage, migration, invasion and breast cancer stem cell responses in vitro. Breast cancer xenograft models were used to demonstrate the consequence of pretreatment with Au and BSO on radiationinduced inhibition of tumor growth, as well as effect on stem cell populations in vivo.
MATERIALS AND METHODS

Cell Lines and Media
MDA-MB-231, MIA PaCa-2 and PANC-1 (ATCCt, Gaithersburg, MD) and SUM159 (Asterland Inc., Detroit, MI) were maintained in media recommended by the suppliers. All cells were grown at 378C, 21% O 2 except for experiments determining stem cells, which were grown at the more physiologically relevant 4% O 2 concentration. Oxygen percentage was measured and maintained with an O 2 sensor installed in the HERAcelle incubator (Thermo Fisher Scientific Inc., Waltham, MA).
Drugs and Irradiation
Cells were treated for 24 h with 0.1-0.5 mM SSZ or 0.1 mM BSO (both acquired from Sigma-Aldricht LLC, St. Louis, MO). Au (Enzo Life Sciences Inc., Farmingdale, NY) was dosed at either 250 or 500 nM for 1-3 h. 2-AAPA was prepared as previously described elsewhere (12) , and was used at 20-100 lM final concentration for 3 h. N-acetylcysteine (NAC, 15 mM; Cumberland Pharmaceuticals Inc., Nashville, TN), or PEG-Catalase 100 U/ml (Sigma-Aldrich) were added simultaneously with BSO or SSZ. For the PEG control, methoxypolyethylene glycol tresylate (Sigma-Aldrich) was used at a final concentration of 0.1 mg/ml. Cells were 2 Gy irradiated (dose rate, 0.365 Gy/min) using a cesium-37 source (JL Shepherd & Associates, San Fernando, CA).
Clonogenic Survival Assay
Exponentially growing cells were treated as described above. Attached cells were collected using 0.25% trypsin and combined with floating cells. After resuspension in fresh media the cells were counted, plated at low densities, and allowed to grow for 11-14 days. Surviving fractions were calculated as described previously and normalized to vehicle-treated plates (7) . Cell numbers after Au treatment were corrected to the cell number on vehicle-treated dishes to account for the loss of cell-sized particles caused by immediate toxicity.
Western Blot Assays
Exponentially growing MDA-MB-231 cells were treated with BSO and Au as described above. Cells were scraped 1 h after irradiation into ice cold RIPA buffer containing cOmpletee Mini Protease Inhibitor and PhosSTOPe phosphatase inhibitor (Roche Diagnostics, Indianapolis, IN). After sonication the samples were centrifuged for 10 min at 48C. Protein concentrations were determined by BCA method. Gamma-H2AX Western blot analysis was performed using polyclonal anti-phos-H2AX Ser139 (cat. no. 07-164; Upstate Biotechnology, Lake Placid, NY) running approximately 20 lg of protein per lane on four separate occasions, electrophoresed on 15% SDS-polyacrylamide gels and transferred onto PVDF membranes. Bands were detected using ECL Western Blotting Detection System (GE Healthcare BioSciences, Pittsburgh, PA) with detection by X-ray film. Bandintegrated densities were determined with ImageJ software (National Institutes of Health, Bethesda, MD) and averaged between four gels, each normalized to its own alpha-tubulin loading control.
Thioredoxin Reductase and Glutathione Reductase Assay
Exponentially growing cells on 100-mm dishes were treated as described above then harvested by scraping and frozen as a dry pellet until assayed. Cell pellets were lysed in 50 mM potassium phosphate buffer (pH 7.8) containing 1.34 mM diethylenetriaminepentaacetic acid, centrifuged at 5,000 rpm for 5 min and then the supernatant was assayed using a TrxR assay kit (Sigma-Aldrich). For GR assay 30 mM GSSG, 1% BSA and 0.8 mM NADPH and PBS were mixed, allowed to incubate 1-2 min, after which the sample was added, and the rate of NADPH disappearance was measured at 340 nm. Units of GR activity were expressed by comparison to a standard curve after the blank rate was subtracted from the sample. GR and TrxR activity were normalized using the Lowry protein assay.
Glutathione Assay
Cells were grown and processed, similar to the TrxR assay, except cells were scraped into 300 ll of 5% 5-sulfosalicylic acid (Sigma-Aldrich) and stored frozen for a maximum of 72 h. Total GSH content was determined spectrophotometrically by NADPH recycling assay, as described previously. (7) Matrigel Invasion Assay MDA-MB-231 cells were plated, similar to the clonogenic assay. Cells were treated with 15 mM NAC and 100 lM BSO for 24 h, 500 nM Au was added during the final hour of treatment, and culture dishes were then 2 Gy irradiated. Media was then refreshed and the plates were placed back in the incubator for 2.5 h. Cells were then trypsinized and live cells were determined using the trypan blue assay via Countesse (Invitrogene, Carlsbad, CA) and reseeded at 2.5 3 10 4 live cells in migration or invasion chambers (BD Biocoate; BD Biosciences, Franklin Lakes, NJ) in serum-free media. Media containing fetal bovine serum (FBS) was placed in the bottom chamber. After 16 h incubation, noninvading cells were scrubbed from the top surface and the membranes were stained with Giemsa violet. Cells were counted on four distinct quadrants of each chamber and averaged, and the experiment was repeated at least four times.
CD44/CD24/CD326 Flow Cytometry
MDA-MB-231 exponentially growing on 100-mm dishes at 4% O 2 378C were treated with 500 nM Au or vehicle control followed in 1 h by 2 Gy irradiation and re-placed into the incubator. Cells were again 2 Gy irradiated 24 h later. Approximately 1 h after irradiation the cells were disassociated with trypsin, counted and 1 million cells were resuspended in 100 ll staining buffer (DPBS containing HEPES and 2% FBS). Cells were stained with PE anti-human CD24, APC antihuman CD326 (EpCAM, ESA), Brilliant Violet (BV) 421e antihuman CD44 on ice for 30 min (BioLegendt Inc., San Diego, CA). Cells were stained with Hoechst for live/dead determination and 100,000 cells processed through a Becton Dickinson LSR II with 405, 488, 561 and 639 nm lasers (BD Biosciences). Compensation was calculated and gates were set using fluorescence minus one with added isotype control. The reported results are from three distinct experiments.
Tumor Xenograft Growth
Animals were housed in the animal care facility at the University of Iowa, which has a PHS Animal Welfare Assurance, is registered with the U.S. Department of Agriculture and is accredited by the Association for Accreditation of Laboratory Animal Care. All animal protocols were reviewed by the Institutional Animal Care and Use Committee. MDA-MB-231 cells (8 3 10 6 ) that were previously isolated from an aggressive-growing mouse xenograft, then grown in culture as before, were injected subcutaneously into the right flank of 8-week-old female nu/nu mice (Harlant Laboratories Inc., Indianapolis, IN). When tumor volumes measured 100 mm 3 , mice were divided into groups of 5-7 animals each and given drugs intraperitoneally (i.p.). Vehicles, BSO and Au were prepared as described previously elsewhere (6) . BSO was administered at 450 mg/ kg and Au was administered at 1.7 mg/kg 2 h after BSO. All mice were anesthetized using 87.5 mg/kg ketamine and 12.5 mg/kg xylazine mixture and mice that were to be irradiated were placed in a lead box with only the right flank exposed. Mice were 6 Gy irradiated, using a Pantak Therapax DXT 300 X-ray machine (200 kVp with added filtration of 0.35 mm copper and 1.5 mm aluminum). All treatments were repeated 48 h later. Weights and tumors volumes were measured daily [volume ¼ (length 3 width i.p. injections of BSO 675 mg/kg followed 2 h later by Au 2.7 mg/kg and 4 h later by 6 Gy irradiation. Tumors were harvested 20 h postirradiation and digested in collagenase/hyaluronidase (STEMCELLe Technologies Inc., Vancouver, Canada) containing media at 378C, agitated with a pipette every 10 min for 40 min, then strained through a 70 lm nylon filter into media containing FBS on ice. Cells were labeled with anti-mouse MHC-APC (eBioscience Inc., San Diego, CA), after which the ALDEFLUORe kit (STEMCELL Technologies) was used to determine the population with a high ALDH1 enzymatic activity. Hoechst dye was added to determine viability. Samples were analyzed using a Becton Dickinson LSR II flow cytometer (BD Biosciences). The number of ALDH þ cells of 100,000 live cells was determined by using the sorting gate established with DEAB containing samples.
SNARF-1 Flow Cytometry
SUM159 xenografts were grown and harvested as mentioned above and a single cell suspension was placed in a tissue culture flask and grown at 4% O 2 378C for 24 h. Select dishes were treated with 1 mM BSO for an additional 24 h. The fluorescent dye, 5-(and-6)-chloromethyl SNARF-1 acetate (SNARF-1) (Molecular Probest, Eugene, OR), was resuspended in DMSO to make a 1 mM stock solution. SUM159 cells (1 3 10 6 ) were resuspended in ALDH buffer containing 10 lM SNARF-1 and ALDH 6 DEAB for 30 min at 378C (17) . After incubation cells were resuspended in ALDH buffer and analyzed as before, additionally using the argon 561 laser with 610/20 band pass filter to determine SNARF-1 mean fluorescence intensity on a minimum of 5,000 ALDH þ cells.
Statistical Analysis
All in vitro experiments were repeated at least three times. Statistical analysis was performed with one-way ANOVA with Newman-Keuls post hoc test for multiple comparisons or Student's t test for comparison of individual groups. For tumor growth rate and survival of animal experiments the log-rank test was used to compare survival between treatment groups and a linear mixed effects regression model to estimate and compare group-specific tumor growth curves. A natural log transformation on the tumor size variable achieved the best fit for the model based on AIC. All tests were twosided and performed at the 5% level of significance. Analyses were performed with SASt version 9.3 software (SAS Institute Inc., Cary, NC).
RESULTS
Au, BSO and SSZ Inhibit the GSH and Trx Pathway
Treatment with Au and BSO in breast, prostate and lung cancer cells has been reported to increase oxidized GSH and Trx as well as to sensitize the cells to chemotherapy agents (7, 8, 18) . Figure 1A shows that Au is effective at significantly inhibiting TrxR activity in breast (63% decrease in SUM159 cells at 50 nM and 27% decrease in MDA-MB-231 cells at 250 nM) and pancreatic cancer cell lines (75% decrease in PANC-1 cells at 1,500 nM and 63% decrease in MIA PaCa-2 cells at 1,500 nM). Figure 1B shows that treatment with BSO or SSZ resulted in decreased GSH levels in MIA PaCa-2, PANC-1 and MDA-MB-231 cell lines with higher doses of SSZ needed to get equivalent decreases as with BSO (Fig. 1B) . Au as a single agent did not alter GSH levels in the four cell lines tested. In addition, when Au was combined with 200 lM SSZ, GSH levels were not significantly different from 200 lM SSZ alone, demonstrating that Au did not directly affect GSH levels. Clonogenic survival assays showed 200 lM SSZ resulted in significant cell killing in PANC-1 and MDA-MB-231 cells (19 and 25%, respectively) . Treatment with Au for 3 h resulted in significant clonogenic killing of PANC-1 and MDA-MB-231 cells [14 and 29%, respectively (Fig. 1C)] . Combined Au and SSZ treatment on PANC-1, MDA-MB-231 and MIA PaCa-2 cell lines resulted in significant decreases in survival (29%, 54% and 43%, respectively) that were completely reversed with NAC, confirming a thiol-mediated cell death mechanism (Fig. 1C) . In SUM159 where SSZ did not deplete GSH levels, combined Au and SSZ treatment did not result in significant cell death (Fig.  1B and C) . These results indicate that inhibition of the x c -transporter is effective at decreasing GSH levels and results in cell death in combination with inhibition of TrxR in some human cancer cell lines.
2-AAPA Inhibits GR and TrxR, and Results in Decreased Clonogenic Cell Viability
Zhao et al. previously reported a time-and dosedependent inhibition of GR in cancer cells using the novel inhibitor 2-AAPA (14) . Figure 2A and C confirm that 2-AAPA caused a dose-dependent decrease in GR activity that was accompanied by a dose-dependent decrease in survival. NAC completely inhibited the cytotoxicity of 40 lM 2-AAPA in both cell lines, confirming that cell killing is mediated by disruption in thiol metabolism. Because inhibition of the GSH metabolism alone would not be expected to result in the level of cell killing mediated by 2-AAPA, the effect of 2-AAPA on TrxR activity was determined (Fig. 2B) . Interestingly, 2-AAPA was found to significantly inhibit TrxR activity in both cell lines, in a dose dependent fashion firmly establishing that 2-AAPA inhibits both Trx and GSH metabolism ( Fig. 2A and B) .
Simultaneous Inhibition of the Trx and GSH Metabolism Enhances Radiation Responses
Combined 2-AAPA and 2 Gy radiation treatment caused significantly more clonogenic killing than either treatment alone in MDA-MB-231 cells, but not in SUM159 breast cancer cells (Fig. 3A) . Treatment of breast cancer cells with BSO for 24 h [resulting in a 65-85% decrease in GSH (Fig.  1B) ] or Au for the last hour as single agents [resulting in 66% and 25% decrease in TrxR activity, respectively (Fig.  1A) ] did not significantly reduce clonogenic survival or enhance the response to 2 Gy irradiation (Fig. 3B) . In contrast, with combined BSO and Au treatment, significant (50-60%) increases in clonogenic cell killing were noted in MDA-MB-231 and SUM159, respectively, which appeared to be at least additive when combined with 2 Gy irradiation (Fig. 3B) .
To determine the sensitizer enhancement ratio (SER) of Au and BSO on breast cancer cells, MDA-MB-231 cells were treated with 100 lM BSO for 24 h and/or Au 0.5 lM for 1 h, then irradiated at varying doses followed by clonogenic survival assay (Fig. 3C-E) . Au, BSO, and the combination significantly enhanced radiation responses (SER 1.12, 1.11, and 1.15, respectively) at 1% iso-survival when normalized to plating efficiency in the presence of drug alone.
Simultaneous inhibition of GSH and Trx metabolism in PANC-1 cells with combination Au and SSZ treatment prior to 2 Gy irradiation also appeared to cause additive cell killing (Fig. 3B) . When PANC-1 cells were pretreated with Au and SSZ in the presence of 100 U/ml polyethylene glycol conjugated catalase (PEG-CAT) to scavenge H 2 O 2 , both the cell killing and the additive response to 2 Gy irradiation were inhibited. These results support the conclusion that the cell killing and enhanced response to radiation seen in PANC-1 cells treated with inhibitors of GSH-and Trx-dependent metabolism are mediated by H 2 O 2 , supporting the hypothesis that Au and SSZ compromise H 2 O 2 metabolism.
Cells were harvested for Western blots using immunoreactive phosphorylated histone H2AX (c-H2AX), a marker of DNA double-strand breaks (DSBs), 1 h after treatment of MDA-MB-231 cells with combinations of Au 0.5 lM, BSO 100 lM and 2 Gy radiation. As expected, c-H2AX significantly increased in MDA-MB-231 cells treated with radiation (Fig. 4) . Neither 0.5 lM Au nor 100 lM BSO alone increased c-H2AX in irradiated cells. In contrast, the combined Au and BSO treatment significantly increased c-H2AX (P ¼ 0.03), indicating an increase in steady-state level of DNA DSBs after irradiation in the cells demonstrating enhanced radiosensitivity. These results support the conclusion that inhibition of GSH and Trx metabolism enhances radiosensitivity in human breast cancer cells in vitro through a mechanism involving enhanced DNA damage.
Disruption of Redox Balance Inhibits Cancer Cell Migration and Invasion and Radiosensitizes Cancer Stem Cells
There is recently reported evidence to suggest that the cancer cell's ability to invade surrounding tissue is dependent of epithelial-mesenchymal transition (EMT) factors, which may be modulated by redox balance (19, 20) . Figure 5 shows that combined Au and BSO treatment in the presence and absence of radiation significantly decreased the ability of MDA-MB-231 cells to migrate through both control membranes (Fig. 5A) as well as Matrigelt basement membranes (Fig. 5B) . Furthermore, the ability of Au with BSO to inhibit invasion and migration was abrogated by treatment with NAC, supporting the conclusion that this biological effect was caused by compromised GSH-and Trx-dependent thiol metabolism ( Fig. 5A and B) . Notably, treating with either Au or BSO before irradiation did not significantly affect migration through the control membrane (Fig. 5A ) but did significantly decrease the cells' ability to invade the Matrigel membrane (Fig. 5B) , which is consistent with previously reported studies (21) .
Considering the results in Fig. 5B and because it has been reported that cancer stem cells are resistant to radiation, we investigated the effects of Au combined with radiation treatment on the subpopulation of cancer stem cells. It has been shown that a small population of MDA-MB-231 breast cancer EMT-like cells exhibit self-renewal capacity and grow tumors in animals when injected in small numbers (as few as 100 cells) (22) . It has also been reported that a subpopulation of stem-like cells was identified in SUM159 cells using aldehyde dehydrogenase 1 activity (ALDH1) (23) . MDA-MB-231 and SUM159 cells were treated with and without Au (500 nM) followed by 4 Gy irradiation (in 2 Gy fractions 24 h apart). MDA-MB-231 cells were then stained for CD44 high , CD24 low and CD326 þ (also known as EpCAM or epithelial-specific antigen) expressing cells (Fig.  5C ). SUM159 cells were stained for ALDH1 (Fig. 5D) . Interestingly, radiation exposure resulted in an increase in the percentage of viable (Hoechst negative) stem cells, supporting the hypothesis that this subpopulation of breast cancer cells is resistant to radiation; however, pretreatment with Au was able to resensitize this population, resulting in a decrease in the percentage of viable stem cells in both cell lines (Fig. 5C and D) .
FIG. 3. Simultaneous inhibition of Trx and GSH metabolism enhances radiation response. Panel A:
Normalized clonogenic survival is shown for MDA-MB-231 (black bars) and SUM159 cells (gray bars). 2-AAPA treatment for 3 h was followed by 2 Gy irradiation. *P , 0.05 vs. control; d P , 0.05 vs. treatment groups alone. Panel B: PANC-1 cells were treated 24 h with 100 units/ml PEG-CAT or PEG alone, 200 lM SSZ and 500 nM Au for the last 3 h of incubation followed by 2 Gy irradiation. *P , 0.05 vs. control; **P , 0.05 vs. treatments alone; a P , 0.05 vs. treatment without PEG-CAT. Error bars represent 61 SEM of at least three separate experiments. Panels C-E: MDA-MB-231 cells were treated with 100 lM BSO for 24 h and/or 500 nM Au for 1 h followed by 1, 2, 4, 6 and 8 Gy irradiation immediately followed by clonogenic survival assay. Results were normalized to treatment alone and the resulting graph analyzed using IGOR Pro 6.36. Panel F: Normalized clonogenic survival is shown for MDA-MB-231 (black bars) and SUM159 cells (gray bars). 100 lM BSO for 24 h and Au (250 nM SUM159 or 500 nM MDA-MB-231) for the last hour, followed by 2 Gy irradiation. *P , 0.05 vs. control; 
Au and BSO Treatment before Irradiation Increases Mouse Survival and Decreases Breast Cancer Progenitor Stem Cell Survival In Vivo
Mice bearing MDA-MB-231 xenografts were pretreated with BSO and Au followed by radiation exposure every 48 h for two 6 Gy doses. Mice treated with Au and BSO showed no changes in behavior or activity but lost an average of 1.2 g in body weight (;5% of body weight) during treatments. However, by one week after treatment the mice had regained weight and were identical to controls, indicating all treatments were well tolerated. Treatment with Au and BSO appeared to result in a slight and insignificant increase in tumor growth rate over control mice, possibly due to infrequent dosing and the relatively large tumor sizes at the start of treatment (5-8 mm diameter). The mean of the tumor volumes on day 41 (the day that the first mouse in the control group reached criteria for euthanasia) was significantly reduced in the mice pretreated with combined Au and BSO before irradiation compared to mice that were irradiated only (P ¼ 0.02) (Fig. 6A) . When all the growth curves were fitted using mixed linear regression analysis, the growth curve of the irradiated only group did not reach significance (P ¼ 0.07) relative to control. In contrast, the growth curve for the irradiated group treated with Au and BSO was significantly different from the control (P ¼ 0.009) (Supplementary Fig. S1 ; http://dx.doi.org/10.1667/ RR14463.1.S1), but differences between the radiation only and radiation with Au and BSO treatment groups did not reach statistical significance (P ¼ 0.24) (Supplementary Fig.  S1 ). When time to tumor regrowth was compared using a log-rank test (Supplementary Fig. S2 ), mice treated with radiation, Au and BSO showed a trend toward slower regrowth, relative to radiation only, which again did not reach statistical significance (P ¼ 0.08). Kaplan-Meier survival curves also showed that the combined Au and BSO treatment as well as the radiation only groups did not differ significantly from control (P ¼ 0.58 and P ¼ 0.15, respectively), however survival of mice treated with radiation, Au and BSO was significantly different from control (P ¼ 0.013) (Fig. 6B) .
Flow cytometric studies, using chloromethyl SNARF-1 acetate (CM-SNARF, a dye that forms covalent adducts with intracellular reduced thiols) (17) along with ALDH1 activity, demonstrated that breast cancer stem cells (ALHD1 þ ) derived from SUM159 mouse xenografts have more total reduced thiols than nonstem cells (ALDH -) (Fig.  6C) . Furthermore, the treatments with BSO, shown to deplete .90% of total GSH (8), revealed that both the fraction of reduced thiols representing GSH (BSO sensitive) as well as the fraction of thiols that remains after GSH depletion were greater in ALDH1 þ stem cells, relative to the bulk tumor cell population (Fig. 6C) . These results extend observations by Diehn et al. (4) and show that breast cancer stem cells have greater levels of both GSH-and nonGSHdependent thiols.
ALDH1 was measured in SUM159 xenografts 20 h after 6 Gy irradiation and, consistent with the in vitro data, showed that irradiated tumors have a significantly greater number of ALDH þ cells relative to controls (Fig. 6D ). Pretreatment with combined Au and BSO resulted in a significant decrease in ALDH1 þ cells and inhibited the radiation-induced increase in ALDH1 þ cells. Interestingly, pretreatment with combined Au and BSO before irradiation also resulted in significantly fewer ALDH þ cells compared to either irradiated only tumors or control tumors (Fig. 6D) . Overall the results in Fig. 6 demonstrate the increased thiol antioxidant capacity of breast cancer stem cells and the effect of manipulating cellular thiols on the responses of breast cancer stem cells that could contribute to radiation resistance.
DISCUSSION
GSH is an essential cofactor for all glutathione peroxidase and glutathione transferase enzymes that detoxify hydroperoxides and electrophiles produced as byproducts of oxidative stress (24) . Likewise, Trx acts as a cofactor in the peroxiredoxin-mediated detoxification of hydroperoxides (6) . Trx and peroxiredoxins have been shown to be overexpressed in human breast carcinomas (6) and total GSH content has been shown to be significantly increased in breast cancers and correlated with poor outcomes (25) . Recently, we reported that simultaneous inhibition of both Trx-and GSH-dependent metabolism was required to achieve the most effective sensitization of human lung and breast cancer cells to chemotherapeutic agents (7, 8) , most likely because of redundancies between the GSH-and Trx-dependent pathways for hydroperoxide metabolism. In   FIG. 4 . Addition of Au and BSO to radiation treatment increases DNA damage in breast cancer cells. MDA-MB-231 cells were treated with 100 lM BSO for 24 h, 500 nM Au for 1 h followed by 2 Gy irradiation. Cells were harvested and analyzed using Western blot analysis with a c-H2AX antibody and an a tubulin loading control. The gels from four independent experiments were quantified using ImageJ. *P , 0.03. the current study, we extended this research to examine radiation responses after manipulation with therapeutically relevant thiol-modifying agents as well as combined manipulations of glutathione and thioredoxin metabolism in early progenitor breast cancer stem cells.
SSZ, 2-AAPA and BSO were used to inhibit GSH metabolism and Au as well as 2-AAPA were used to inhibit Trx metabolism (Figs. 1 and 2 ). When 60-80% decreases in GSH content were achieved with SSZ and combined with Au, enhancement of radiation response was seen in 3 of the 4 cell lines tested (Fig. 3) . Although the 200 lM concentration of SSZ that is needed to achieve these results in vitro is not achievable using current oral dosing, this may be managed with intravenous dosing (26) . Unexpectedly, the GR inhibitor, 2-AAPA, was also found to be an effective TrxR inhibitor, suggesting a broad spectrum reactivity with thiol-containing enzymes (Fig. 2) . From the current results comparing effective doses of SSZ and BSO for depleting GSH (Fig. 1B) , the most effective combination of manipulating GSH and Trx metabolism that was also tolerated in vivo appeared to be BSO with Au. Furthermore, when pancreatic and breast cancer cells were irradiated, we found that the combined inhibition of the GSH and Trx metabolism was also required to enhance radiation responses (Figs. 3-6 ). The mechanism(s) responsible for these effects clearly involved disruptions in thiol and hydroperoxide metabolism, as evidenced by the ability of NAC and PEG-CAT to mitigate the toxic effects in cancer cells (Figs. 1C, 2C, 3B, 5A and B) .
Farina et al. recently hypothesized an important role for Trx-1 in the invasive phenotype of breast cancer cells, by a mechanism where Trx-1 overexpression stimulates matrix metalloproteinase, resulting in a more invasive phenotype (21) . The current studies clearly show that combined Au and BSO treatment was needed to achieve maximal inhibition of migration and invasion in vitro (Fig. 5A and  B) . In contrast, either Au or BSO as single agents combined with radiation decreased the ability of breast cancer cells to invade Matrigel basement membranes. These effects of Au with BSO on migration and invasion mitigated by NAC clearly support the importance of thiol metabolism as a critical regulator of the invasive phenotype in human breast cancer cells (Fig. 5) .
Cancer stem cells are capable of self-renewal and are thought to represent a critical cancer cell subpopulation that determines treatment outcome (3, 4) . In previously reported work, intracellular redox status has been suggested as a critical factor regulating stem cell self-renewal and altering the redox balance by inhibiting the xCT cystine transporter in breast cancer cells, impairing tumor-sphere generation, delaying tumor growth and decreasing metastasis (26) (27) (28) . Breast cancer stem cells have been suggested to govern tumor recurrence because they are reported to produce lower steady-state levels of pro-oxidants, relative to bulk tumor cells, leading to radioresistance (3, 4) . While radiation therapy effectively shrinks tumors and is considered the standard of care for many breast cancer patients, previously reported findings as well as the results in the current study have demonstrated that a subpopulation of breast cancer cells appear to be resistant to radiation (Figs.  5C, D and 6D) . In vitro radioresistance of breast cancer stem cells has been reported to be partially abrogated by pharmacologically depleting GSH with BSO (4) and the current study clearly demonstrates that inhibition of TrxR with Au is also effective at decreasing the percentage of ALDH1 þ breast cancer stem cells after irradiation ( Fig. 5C  and D) . In addition, the current study also clearly demonstrates (using ALDH1 as a marker for breast cancer stem cells) that the percentage of viable breast cancer stem cells in xenografts also increases after irradiation, and this is significantly reduced by pretreatment with Au and BSO (Fig. 6D) .
Notably, the data shown in Fig. 6A and B also support the potential for these combinations to improve tumor responses to radiation, since three animals showed no evidence of disease after treatment with Au, BSO and radiation, whereas only one animal remained disease free after radiation treatment only. While these data support the conclusion that radiation was the dominant treatment modality required for the antitumor effects, the tumors in this experiment were all between 5 and 8 mm in diameter at the beginning of drug and radiation treatments. This tumor size may have affected the uniformity of drug distribution to a greater extent than the uniformity of radiation dose, contributing to the fact that the radiation was the main reason for the antitumor effect. Most importantly, the groups that received Au and BSO treatment with 2 3 6 Gy irradiation, relative to radiation alone, did respond significantly better when mean tumor volumes were compared at 41 days (the time point at which the first control mouse died), and did clearly show a more significant growth inhibition (Supplementary Fig. S1 ; http:// dx.doi.org/10.1667/RR14463.1.S1) relative to control.
Overall, the results of the current study support the overarching hypothesis that intracellular thiol redox status governed by GSH-and Trx-dependent metabolism are critical regulators of the invasive/metastatic phenotype of human breast cancer cells. Furthermore, these results highlight the importance of designing combined modality cancer therapies targeting both GSH-and Trx-dependent metabolism to enhance radiation responses.
